巨星医疗控股(02393.HK)盈警：预计中期综合纯利大幅减少至不少于1000万元

Core Viewpoint - The company, Giant Star Medical Holdings (02393.HK), anticipates a significant decline in its unaudited consolidated profit for the mid-2025 period, projecting it to be no less than RMB 10 million compared to approximately RMB 1.093 billion for the mid-2024 period [1] Financial Performance - The expected substantial decrease in profit for the mid-2025 period is primarily attributed to the absence of a profit of approximately RMB 1.083 billion recognized in the mid-2024 period due to the redemption of the company's originally scheduled 2026 maturity preferred notes at a discounted price [1] - Additionally, there is a reduction in revenue from the medical products segment contributing to the decline in profit [1]